$23.09
-0.27-1.16%
At close: -
$23.21
0.120.52%
After Hours: 4:01 PM EDT
Comments
Loading...
Kiniksa Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:KNSA | Benzinga
Kiniksa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 22
EPS Estimate
$0.240
Quarterly Revenue Estimate
$135.35M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$423.24M
Analyze the earnings history of Kiniksa Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals | -$0.25 | $0.24 | — | — | $79.86M | $135.35M | — | — | 04/22/2025 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | $0.35 | $0.13 | -$0.12 | -192.31% | $83.39M | $123.38M | $122.54M | -0.68% | 02/25/2025 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.20 | $0.03 | -$0.18 | -700.00% | $67.05M | $111.52M | $112.21M | 0.62% | 10/29/2024 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.02 | -$0.07 | -$0.06 | 14.29% | $71.47M | $92.31M | $108.63M | 17.68% | 07/23/2024 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.18 | -$0.16 | -$0.25 | -56.25% | $48.34M | $78.46M | $79.86M | 1.78% | 04/23/2024 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | $0.06 | -$0.14 | $0.35 | 350.00% | $61.88M | $72.02M | $83.39M | 15.79% | 02/28/2024 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | $3.18 | -$0.17 | -$0.20 | -17.65% | $99.14M | $64.45M | $67.05M | 4.03% | 10/31/2023 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.29 | -$0.17 | -$0.02 | 88.24% | $26.97M | $52.20M | $71.47M | 36.92% | 07/25/2023 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.36 | -$0.21 | -$0.18 | 14.29% | $32.19M | $46.58M | $48.34M | 3.79% | 05/02/2023 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.53 | -$0.23 | $0.06 | 126.09% | $18.75M | $45.11M | $61.88M | 37.18% | 02/28/2023 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.44 | $0.50 | $3.18 | 536.00% | $12.10M | $74.39M | $99.14M | 33.26% | 11/01/2022 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.61 | -$0.44 | -$0.29 | 34.09% | $7.70M | $28.55M | $26.97M | -5.53% | 08/03/2022 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.72 | -$0.41 | -$0.36 | 12.20% | $0.00 | $22.77M | $32.19M | 41.37% | 05/03/2022 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.79 | -$0.42 | -$0.53 | -26.19% | $0.00 | $20.72M | $18.75M | -9.53% | 02/22/2022 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.66 | -$0.65 | -$0.44 | 32.31% | $0.00 | $10.18M | $12.10M | 18.81% | 11/01/2021 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.65 | -$0.79 | -$0.61 | 22.78% | $0.00 | $3.97M | $7.70M | 94.06% | 08/03/2021 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.48 | -$0.80 | -$0.72 | 10.00% | $0.00 | $3.72M | $0.00 | -100.00% | 05/04/2021 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.58 | — | -$0.79 | — | $0.00 | — | $0.00 | — | 02/23/2021 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.49 | — | -$0.66 | — | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$0.68 | — | -$0.65 | — | $0.00 | — | $0.00 | — | 07/30/2020 | Get Alert |
| KNSA | Kiniksa Pharmaceuticals | -$1.27 | -$0.63 | -$0.48 | 23.81% | $0.00 | — | $0.00 | — | 04/28/2020 | Get Alert |
Kiniksa Pharmaceuticals (KNSA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $-0.12 | $0.13 | -192.3 % |
| Q3 | 2024-10-29 | $-0.18 | $0.03 | -700.0 % |
| Q2 | 2024-07-23 | $-0.06 | $-0.07 | 14.3 % |
| Q1 | 2024-04-23 | $-0.25 | $-0.16 | -56.3 % |
Kiniksa Pharmaceuticals (KNSA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $122.54M | $123.38M | -0.68 % |
| Q3 | 2024-10-29 | $112.21M | $111.52M | 0.62 % |
| Q2 | 2024-07-23 | $108.63M | $92.31M | 17.7 % |
| Q1 | 2024-04-23 | $79.86M | $78.46M | 1.78 % |
FAQ
When is Kiniksa Pharmaceuticals (NASDAQ:KNSA) reporting earnings?
Kiniksa Pharmaceuticals (KNSA) is scheduled to report earnings on April 22, 2025. The last reported earnings were for reported on February 25, 2025 for Q4.
What were the latest earnings per share (EPS) for Kiniksa Pharmaceuticals (NASDAQ:KNSA)?
The Actual EPS was $-0.12, which missed the estimate of $0.13.
What were Kiniksa Pharmaceuticals’s (NASDAQ:KNSA) revenues?
The Actual Revenue was $122.5M, which missed the estimate of $123.4M.
Browse earnings estimates, EPS, and revenue on all stocks.